MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2016 International Congress

    Transcranial unilateral MR guided high intensity focused ultrasound in Parkinson’s disease or essential tremor seems to be save concerning dysphagia and dysarthria

    S. Hägele-Link, N.A. Wegener, S.R. Schreglmann, J. Rosenfeld, M. Mueller-Baumberger, R. Bauer, A. Lebeda, B. Werner, E. Martin, G. Kägi (St. Gallen, Switzerland)

    Objective: To report first results of a study monitoring speech and swallowing function after lesional functional neurosurgery for movement disorders. Background: Transcranial MR-guided high intensity…
  • 2016 International Congress

    Imaging-based differential diagnosis between multiple system atrophy and Parkinson’s disease

    W. Sako, T. Abe, N. Murakami, Y. Miyazaki, Y. Izumi, M. Harada, R. Kaji (Tokushima, Japan)

    Objective: We aimed to directly compare middle cerebellar peduncle (MCP) width, apparent diffusion coefficient (ADC) value of the putamen and cerebellum, and 123I-metaiodobenzylguanidine (MIBG) myocardial…
  • 2016 International Congress

    Unawareness of causes of sudden deterioration in Parkinson’s patients in movement disorder clinic

    V. Paramanandam, D.A. Olszewska, C. Fearon, B. Magennis, T. Lynch (Dublin, Ireland)

    Objective: To evaluate patient's awareness of reversible causes of worsening of Parkinson's disease (PD)1, their impact on symptoms and the role of abdominal x-ray (PFA)…
  • 2016 International Congress

    Cognitive impairment in Parkinson’s disease

    B. Kurbanov (Tashkent, Uzbekistan)

    Objective: To study features of cognitive symptoms in PD, depending on the severity of the disease. Background: Parkinson's disease (PD) is shown a wide range…
  • 2016 International Congress

    Comparative gait analysis of patients with vascular parkinsonism and idiopathic Parkinson’s disease

    B. Mondal, S. Choudhury, M.U. Kulsum, P. Chatterjee, S. Chatterjee, K. Chatterjee, R. Banerjee, S.S. Jha, S.S. Anand, H. Kumar (Kolkata, India)

    Objective: In this study we intended to characterize and compare the gait parameters of vascular parkinsonism (VaP) and Idiopathic Parkinson's disease (IPD) patients using validated…
  • 2016 International Congress

    Innsbruck multiple system atrophy cohort study – An interim analysis

    S. Eschlböck, T. Benke, S. Bösch, A. Djamshidian-Tehrani1, A. Fanciulli, R. Granata, C. Kaindlstorfer, G. Kiss, F. Krismer, K. Mair, M. Nocker, C. Raccagni, C. Scherfler, K. Seppi, W. Poewe, G. Wenning (Innsbruck, Austria)

    Objective: To characterize the clinical presentation, to identify markers of disease progression and to assess diagnostic utility of 'red flags' in subjects with multiple system…
  • 2016 International Congress

    Sleep deprivation (SD) amongst carers of patients with Parkinson’s disease (PD)

    D. Kulatunga, H. Avery, A.K. Chatterjee, A. Plowman, J. Caffrey, S. Pradhan (Reading, United Kingdom)

    Objective: To identify nocturnal symptoms in patients which lead to sleep deprivation in carers of PD patients. Background: SD affects the health status of the…
  • 2016 International Congress

    Chronic levodopa treatment accelerates the disorders of circadian rhythm in 6-OHDA induced Parkinson’s disease model

    S. Li, Y. Wang, W. Liu, D. Lv, C. Liu (Suzhou, People's Republic of China)

    Objective: We aimed to study the effect of levodopa on circadian rhythms in 6-OHDA lesioned rats, and to clarify whether the disturbance of the circadian…
  • 2016 International Congress

    Clinical correlates of depression and anxiety in patients with Parkinson’s disease

    H.D. Hambardzumyan, H.M. Manvelyan (Yerevan, Armenia)

    Objective: To clarify whether depression and anxiety are similar in terms of their associations with other clinical variables. Background: Although depression and anxiety are important…
  • 2016 International Congress

    Validation study of Parkinson anxiety scale, Czech version

    N. Zemanová, M. Baláz (Brno, Czech Republic)

    Objective: The study aims to evaluate psychometric properties of Czech version of Parkinson Anxiety Scale (PAS), new scale developed in 2014 to measure anxiety specifically…
  • « Previous Page
  • 1
  • …
  • 360
  • 361
  • 362
  • 363
  • 364
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley